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Purpose: Stainless steel endovascular stents are inherently thrombogenic sothat thrombus 
accumulates on these devices, leading to acute vessel occlusion. A potential solution to this 
problem is stent surface modification with hydrophilic polymers, which might lirnit 
platelet adhesion and reactivity. 
Methods: N-vinylpyrrolidone (NVP) and potassium sulfopropyl acrylate (KSPA) hydro- 
philie monomers were ~/graft polymerized onto 1 cm e stainless teel slabs and 4 mm 
Palmaz stalnless steel stents. Surface characteristics of modified and plain stainless teel 
stents were then investigated with contact angle and x-ray photoelectron spectroscopy 
measurements, and in vitro and in vivo platelet reactivity was assessed as 1 nindium platelet 
accumulation expressed as counts/min/cm 2. 
Results: Surface modification of stainless steel slabs and stents with both NVP and KSPA 
hydrophilic polymers ignificantly reduced in vitro platelet adhesion (plain = 2249 + 723 
cotmts/min/cm 2, NVP = 428 + 156 counts/min/cm 2, KSPA = 958 + 223 counts/min/ 
cm 2) and in vivo platelet accumulation after 1 hour of blood flow exposure (plain = 
1407 + 796 counts/min/cm 2, NVP = 426 + 175 cotmts/min/cm 2, KSPA = 399 + 124 
counts/min/cm2). In addition, platelet accumulation on modified stents indexed to plain 
stents was lowest in KSPA-modified stents (NVP = 79.3% + 31.7% of plain, 
KSPA = 51.2% -+ 36.2% ofplain). Surface analysis confirmed surface grafting with both 
monomers, and SEM documented smoothing of the irregular surfaces of the stainless teel 
stents after grafting. 
Conclusion: Hydrophilic polymer surface modification of stainless teel stents decreases 
initial steht surface platelet accumulation, which may decrease the risk ofvessel thrombosis 
associated with the use of these devices. (J Vasc SuRa 1995;22:327-36.) 
Arterial recanalization with balloon angioplasty 
has demonstrated the value of restoration of function 
of diseased coronary and peripheral arteries by 
catheter-based techniques. Unfortunately, recanaliza- 
tion failure after this procedure is sufficiently com- 
mon to limit the use of this minimally invasive 
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therapy of arterial occlusive disease. Insertion of 
metallic endovascular p ostheses after balloon dilata- 
tion seals intimal dissections and decreases arterial 
elastic recoil, which decreases the risk of acute 
angioplasty failure.1 In addition, use of metallic stents 
in conjunction with balloon angioplasty of iliae 
arteries may improve long-term arterial patency 
compared with balloon dilatation alone5 However, 
use of metallic stents in infrainguinal or coronary 
arteries is assoeiated with a high ineidence of arterial 
thrombosis, 3,4 likely becanse of thrombus accumula- 
tion within the metallic stent. 
Stainless steel alloys, from which most endolu- 
minal stents are constructed, are inherently throm- 
bogenic, ~and thrombus has been shown to accumu- 
late to some degree on all metallic stents after 
implantation. Stents made of absorbable polymers 
wirh limited surfaee thrombogenicity appear to be an 
appealing solution to this problem, but currently the 
necessary use of thicker materials to achieve suffieient 
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radial strength makes absorbable stents problematic. 6 
In contrast, polymer surface modification of metallic 
stents could achieve improved hemocompatibility 
without increased steht bulk. In addition, polymer- 
modified surfaccs can be used to locally deliver drugs 
in high concentrations, which could inhibit surface 
thrombin formation, reduce local smooth-muscle c ll 
growth, or both. 6 This study investigated the appli- 
cation of unique hydrophilic surface modificafion 
techniques developed at the University of Florida 7 
that have previously been shown to improve material 
hemocompafibility 8 for the prepäration of polymer 
surfäces on a commonly used stainless teel stent to 
äfford minimal platelet reactivity. 
MATERIAL AND METHODS 
Surfaee modificafion and characterizafion 
Hydrophilic N-vinylpyrrolidone (neutral [NVP]) 
and potassium sulfopropyl acrylate (highly anionic 
[KSPA]) monomers were polymerized on plasma- 
treated 1cm 2 × 0.0118 cm thick stainless teel slabs 
and 4 mm (47.5 cm 2 surface area) Palmaz balloon 
expandable stainless steel stents (Johnson and 
Johnson Interventional Co., Warten, N. J.) with a 
plasma-y polymerization technique. 7 Stainless steel 
slabs were of the same alloy as the stainless steel 
stents, and inifial studies were done with these slabs 
becanse 1 cm 2 samples are necessary for subseqnent 
surface characterizätion. Surface modification of 
stainless steel samples was done with a two-stage 
process. After cäreful ultrasonic leaning in tetrachlo- 
roethylene, methanol, and pure water was per- 
formed, the stainless teel surfaces were treated with 
rädiofrequency plasmas with argon followed by hex- 
ane gas phase (50 mtorr, 50 W, 15 minutes for each 
gas) and were then kept in watet for 24 hours at 
ambient temperature. NVP-treated samples were 
then immersed in 100% NVP for 24 hours and were 
immersed in 10% aqueous monomer (wt/wt) and y 
radiation polymerization to 0,15 Mrad total dose. 
KSPA-treated samples received no monomer expo- 
sure before y radiation was performed in 10% aque- 
ous KSPA to 0.15 Mrad. Samples were then washed 
in ultrapure watet at 60 ° C for 48 hours followed by 
oven drying. Surface modificafion thickness with this 
technique was esfimated to be in the range of 0.1 to 
2 t*m by x-ray photoelectron spectrometry and graz- 
ing angle Fourier transform infrared/attenuation t - 
tal reflectance. This process results in permanent 
binding of the surface polymer to the surface of the 
base material as shown by no loss of the hydrograft 
after extensive washing including vigorous ultrasoni- 
fication. These reaction conditions and this low radia- 
tion dose have no effect on the bttlk properfies of the 
stainless teel substrätes. 
The surfaces of plain and modified stainless teel 
samples were then characterized with scanning elec- 
tron microscopy, contact angle measurements, and 
x-ray photoelectron spectrometry (XPS). Contact 
angle measures the wettability of a surface, and 
measurement of the contact angle of highly hydro- 
philic surfaces i best done in water with an air bubble 
method. XPS allows precise determination of the 
elemental composinon of the top 5 nm of the surface 
by determining the spectrum of the energy ofemitted 
electrons after exposure to an energetic x-ray source. 
XPS was done with a KRATOS XSAM (KRATOS; 
Ramsey, N. J.) spectrometer. A surface depth of 5 nm 
was studied with a power of 19 × 10 -3 amps and 
1200 V at 10 -5 vacuum. 
In vitro cell adhesion and protein 
adsorption studies 
Plain and hydrophilic polymer modified stainless 
steel samples wcre examined in vitro for (]) platelet 
adhesion with ll~indium_labeled platelets, (2) endo- 
thelial cell adhesion with lllindium_labele d endothe- 
lial cells, and (3) surface protein adsorption with 
12Slodine-labeled albumin and fibrinogen. All sur- 
faces were studied after at least 1 hour of hydration, 
and ccll adhesion studies wcre donc after samples 
were presoaked in human plasma. Platelet adhesion 
studies were done with human platelets, whereas 
endothelial cell adhesion studics were done with 
porcine pulmonary artery endothelial cells, as previ- 
ously reported by the anthors. 8 Platelets were labeled 
with 1HIndium ordne by a modification of the 
method of Heaton et al., 9 and endothelial cells were 
labeled with the same isotope by the tcchnique 
described by Sharefldn et al. I° Labeling efficiency for 
platelets averaged 72%, whereas labeling efficiency 
for endothelial cells averaged 15%. After plain and 
modified samples with labeled endothelial cells or 
platelets were incnbated for 1 hour, samples were 
washed and sample radioactivity determined in a y 
well counter (Autologic, Abbott Laboratories, North 
Chicago, Ill.). The degree of ceH adhesion was 
expressed as counts/min/cm 2. Surface adsorption of 
labeled proteins was determined after plain and 
modified samples were incubated for i hour in a 1% 
solntion of bovine albumin spiked with 37.5 ~Ci 
(6 × 103 counts/ml) of 125Iodine-labeled bovine 
albumin or in a separate 0.5% solution of bovine 
fibrinogen spiked with 11.3 IxCi (366 × 103 
counts/ml) of 12Slodine-labeled bovine fibrinogen. 
Results were also expresscd as counts/min/cm 2. 
Adsorption of free llqndium or X2Slodine was not 
examincd, but previous work demonstrates the loss 
of 1HIndium from labeled platelets to be < 1% of 
bound radioactivity, s and loss of ~2SIodine from 
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labeled protein also should be minimal during the 
time period of these acute experiments. 
Ex vivo studies of surface platelet aecumulation 
The initial surface thrombogenicity of plain and 
hydrophilic polymer surface-modified stainless teel 
slabs and stents was then investigated by measure- 
ment of labeled platelet accumulation on samples 
placed in acute ex vivo canine carotid jugular arterial 
venous shunts. Flow through such shunts averaged 
300 cc/min (similar to flow through human superfi- 
cial femoral arteries). Mongrel dogs were used, and 
animals were not studied for uniformity of platelet 
function before shunt placemcnt was pefformed. 
Plain and modified stainless teel slabs were placed in 
sections of 4 mm id Silastic tubing with the edge of 
the slabs aligned in the direction of blood flow. Plain 
and modified 4 mm Palmaz stainless teel stents were 
expanded in similar sections of Silastic tubing with 
4 mm coronary artery balloon angioplasty catheters. 
The sections of Silastic tubing containing stainless 
steel slabs or stents were then interposed in the canine 
Silastic arteriovenous shunts (which had been con- 
structed just before the smdy) immediately after an- 
tologous mIndinm-labeled platelets had been re- 
turned to the animal. Anesthesia was 0btäined in each 
animal with short-acting barbiturates and was main- 
tained with Halothane. Test and control samples 
were studied at the same time in each animal, and the 
position of these samples with relation to the direc- 
tion of blood flow was alternated. Animals under- 
went anticoagulation with heparin sulfate, and the 
activated otting time was maintained at >_ 2 times 
control. After 1 hour of exposure to blood flow, 
sections of Silastic tubing containing the samples 
were removed from the shtmts, flushed with heparin- 
ized saline solution, and removed from the Silastic 
tubing. No shunts containing slabs or stents were 
found to be occluded. Radioactivity of the test and 
control samples was then determined in a y weil 
counter (expressed as counts/min/cm 2 surface area), 
after which samples were fixed with Trumps solution 
(4% formalin and 1% glutaraldehyde in phosphate 
buffer) and processed for scänning electron micros- 
copy after adioactivity had been allowed to decay for 
i0 half-lives. This procedure precluded correlation of 
SEM findings with the distribution of sample surface 
radioactivity. 
Statistieal analysis 
In vitro cell adhesion studies and ex vivo shunt 
studies produced multiple group means, which were 
compared by analysis of variance with Duncan's 
multiple range test. Paired data that were generated 
by indexing platelet accumulation on modified 
stents to platelet accumulation on plain stents ex- 
amined in the same animal (n1Indium-labeled plate- 
let accumulation on modified stents/nllndium - 
labeled platelet accumulation on plain stents x 100) 
were examined by Student's t test. Data are pre- 
sented as mean __ 1 SD from the mean, andp values 
<0.5 are considered significant. 
RESULTS 
Contact angle measurements and XPS spectra 
confirmed surface grafting of stainless tccl samples 
with polymers derived from both NVP and KSPA 
monomers (termed in the following discussion poly- 
NVP or poly-KSPA). The mean contact angle of 
plain stainless tcel slabs beforc surface grafting was 
performed was 43 ° +_ 12 ° (moderately hydropho- 
bie). The mcan contact angle of poly-NVP modificd 
stainless teel slabs was 23 ° +_ 3 ° (highly hydrophilic) 
and of poly-KSPA modified stainless teel slabs was 
22 ° +_ 3 ° (highly hydrophilic) (p < 0.01, poly-NVP 
or poly-KSPA vs plain samples), demonstrating a 
significant increase in surface hydrophilicity after 
hydrophilic polymer surface modification. Identifi- 
cafion of an increased nitrogen peak in XPS spectra 
for NVP-modified slabs and stents compared with 
control samplcs (Fig. 1) confirmed surface modifi- 
cation of stainless steel samples with poly-NVP. 
Similarly, identification of a largc sulfur peak in XPS 
specträ for KSPA-modified slabs and stcnts eom- 
päred with control samples cortfirmed surface graft- 
ing with poly-KSPA (Fig. 2). Scanning electron 
microscopy of modified stainless teel slabs did not 
reveal significant differences compared with control 
slabs, which was not surprising because the slabs were 
very smooth and the hydrophilic surface graft on the 
modified samples was less than 1 to 2 ~m in 
thiekness. In contrast, scanning clectron micrographs 
of plain and modified Palmaz stainless steel stents 
demonstrated videncc of smoothing of the irregular 
surface of stents after surface modification (Fig. 3). 
Adhesion of mIndium-labcled platelets to modi- 
fied stainless teel slabs in vitro was significantly ower 
than that to plain stainless steel slabs (Table I). 
In addition, adhesion of platelets to poly-NVP- 
modified slabs was lower than that to poly-KSPA 
slabs. Similarly, adhesion of endothelial cells to 
modified slabs was significantly lower than that to 
plain stainless steel slabs. However, adhesion of 
endothdial cells to poly-NVP grafted slabs and to 
poly-KSPA grafted slabs was equivalent. Surface 
protein adsorption of albumin on poly-NVP modi- 
fied stainless teel slabs (7.18 + 0.89 ng/mm 2, n = 
5) was significantly lower than on plain slabs (9.87 -+ 
0.79 ng/mm 2, n = 5), whereas albumin adsorption 
to poly-KSPA modified slabs (12.2 +_ 1.13 ng/mm 2, 
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Fig. 1. X-ray photoelectron spectroscopy of plain stainless teel slab (top) and poly-NVP 
modified stainless teel slab (bottom). Increased nitrogen peak at 295 eV in bottom spectra 
demonstrates successful surface grafting of stainless steel surface with poly-NVP. 
n = 5) was significantly higher (p < 0.01). Adsorp- 
tion of fibrinogen on poly-NVP-modified slabs 
(7.58 + 0.67 ng/mm 2, n = 5) was also lower 
(p < 0.01) than on plain slabs (56.68 _+ 11.37 
ng/mm 2, n = 5), whereas adsorption on poly-KSPA- 
modified slabs (59.64 + 16.63 ng/mm 2, n = 5) was 
equivalent to adsorption on plain slabs. 
Labeled platelet accumulation after 1 hour of 
blood flow exposure in acute canine arterial venous 
shunts was also significanfly ower on both poly-NVP 
and poly-KSPA surface-modified stainless teel slabs 
compared with plain stainless teel slabs (Table II). 
Similarly, labeled platelet accumulation on poly- 
NVP and poly-KSPA surface-modified, expanded 
stainless steel Palmaz stents after i hour ofblood flow 
exposure was lower than on plain stainless steel 
stents. However, in contrast to in vitro results, in vivo 
platelet accumulation was lower on poly-KSPA- 
modified samples than on poly-NVP modified 
samples, and indexed platelet accumulation n modi- 
fied stents (indexed to platelet accumulation on plain 
stents measured in the same animal) was lowest 
on poly-KSPA modified stents (poly-KSPA = 
51.2% + 36.2% of control versus poly-NVP -- 
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79.3% +_ 31.7% of control, p < 0.01). SEM con- 
firmed significant platelet accumulation on the sur- 
face of plain stainless teel stents after 1 hour of flow 
exposure, whereas polymer surface-modifed stents 
were covered with red and white blood cells and some 
fibrin but few platelets (Fig. 4). 
DISCUSSION 
The surface thrombogenicity of metallic endolu- 
minal prostheses remains a major limitation of the 
use of metallic stents in the treatment of coronary. 
and peripheral vascular disease. Thrombosis occurs 
in up to 30% of superficial femoral arteries 2 and in 
up to 40% of coronary arteries 3 within the first few 
days after balloon angioplasty and stent implanta- 
tion are performed. Because of this risk careful 
anticoagulatlon is necessary when metallic stents are 
used in conjunction with balloon angioplasty, par- 
ticularly in coronary arteries, it Late-vessel occlusion 
caused by thrombosis is also a significant problem 
after stent placement is performed, because throm- 
bus is present on stents removed from animals as 
long as the stent is exposed to circulating bloodl2; 
Palmaz et al. 13 found thrombus still present at 
autopsy on the surface of an iliac artery stent 2 
months after implantation was performed in a 
patient. 
Krupsld et al. 14 have reported that placement of 
Palmaz stents (such as those used in this study) or 
Wallstents (a self-expanding stent made from woven 
wires of a different stainless teel alloy) in chronic 
arterial venous shunts in baboons resulted in signif- 
icant labeled platelet accumulation at the site of the 
stent after 1 hour of flow exposure. Scanning electron 
microscopy of the surface of these stents after 
exposure to circulating blood revealed abundant 
surface platelet deposition, and heparin infusion was 
ineffective in reducing this platelet accumulation. 
These results are similar to the significant platelet 
accumulation on plain Palmaz stents after 1 hour of 
flow exposure in acute canine arteriovenous shunts 
observed in this study. Parsson et al. I2 also demon- 
strated that platelet uptake on Wallstents placed in 
porcine lilac arteries continued to increase for at least 
4 hours after stent implantation, although platelet 
uptake on these metallic stents was significantly less 
than on polyester and polytetrafluoroethylene vascu- 
lar grafts implanted in similar animals. The precise 
cause of the high surface plarelet reactivity of stainless 
steel stents remains unclear, but DePalma et al.~S have 
presented results that suggest that it may be related to 
the surface free energy (which is related to the surface 
charge and contact angle) of stainless teel alloys, 
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Fig. 2. High-resolution x-ray photoelectron spectroscopy 
of plain stainless steel slab (top) and poly-KSPA modified 
stainless steel slab (bottom). Increased sulfur peak at 169 
eV in bottom spectra demonstrates successful surface 
grafting of stainless steel surface withpoly-KSPA. 
from which the stents are constructed, and to the 
surface texture of the stents. 
This study has shown that modification of stain- 
less steel alloy samples and Palmaz stainless teel 
endoluminal stents by covalent attachment of a thin 
hydrophilic polymer layer to the stainless steel surface 
reduces urface platelet adhesion in vitro and initial 
surface platelet accumulation i vivo. Platelet adhe- 
sion in vitro to modified stainless teel slabs was 
reduced most by neutral poly-NVP, whereas platelet 
accumulation after 1 hour of blood flow exposure in 
an acute x vivo shunt was lowest on poly-KSPA- 
modified Palmaz stents. The reason for these con- 
flicting results remains unclear and does not appear to 
be explained by differences in surface protein adsorp- 
tion. It may be related to the observation that NVP 
activates complement in vitro, ~6 which could then 
lead to activation of the extrinsic oagulation path- 
way and to stimulation of leukocytes, which can 
activate platelets. Alternatively, platelet attachment to
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Fig. 3. Scanning electron micrographs of lain (left) and hydrophilic surface modified (right) 
Palmaz stainless steel stents. In higher magnification smdies (bottom), surface of plain stents 
can be seen to be very irregular, and some vidence ofsmoothing ofirregular cut surface, which 
has undergone surface modification with hydrophilic polymer, can be seen. 
Table I. Cellular adhesion m plain and modified stainless teel slabs in vitro 
Stainless teel surface type 
Plain ~ (n = 10) Poly-NVP « (n = 6) Poly-KSPA ~ (n = 10) 
Plateletst 2249 ± 723 428 -+ 156 958 _+ 223 
Endothelial cells$ 960 ± 295 343 -+ 305 137 ± 81 
.11 l indium radioactivity/minute/cm 2. 
?Plain > poly-NVP or poly-KSPA, p < 0.01, poly-KSPA > poly-NVP, p < 0.05. 
:;Plain > poly-NVP or poly-KSPA, p < 0.01, poly-KSPA = poly-NVP. 
the poly-KSPA surface could be less secure than to 
the poly-NVP surface so that platelet &position on 
poly-KSPA could be higher in vitro but lower in vivo 
in response to sheer stress-causing microemboli. 
Both of these possible explanations remain specula- 
tive, because neither complement activation by the 
modified samples nor the generation of microemboli 
was measured in this study. Regardless, platelet 
adhesion to both types of hydrophilic-polymer sur- 
faces was less than that to the plain stainless teel 
surface both in vitro and in vivo. However, only 
overall platelet adhesion was measured, and platelet 
carpeting versus platelet hrombus generation and 
growth (which are clinically more important) were 
not differentiated. In vivo examination of thrombus 
accumulation i  modified stents and the potential for 
microembolization from the modified stent surface 
will be necessary before the true clinical relevance of 
hydrophilic surface modification of metallic stents 
can be determined. 
Hydrophilic polymer surface grafting was less 
effective in reducing surface platelet accumulation on 
stainless steel stents than on stainless steel slabs, 
which may be due to the surface roughness of the 
Palmaz stents, which the very thin (< 1 to 2 I,m) 
surface polymer only partially overcomes. Further 
reduction in steht surface platelet adhesion may be 
necessary to prevent surface thrombus accumulation 
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Table II. Platelet accumulation on plain and modified stainless teel slabs and stents in vitro 
Stainless teel surface 
Plain ~ (n = 5) Poly-NVP ~ (n = 5) Poly-KSPA ~ (n = 5) 
Stainless teel slabs~ 1407 _+ 796 426 _+ 175 399 -+ 124 
Stainless teel stents~ 4887 +- 2596 3703 _+ 2224 2281 + 1652 
n qnd ium radioactivi~/minute/cm 2. 
~Plain > poly-NVP or poly-KSPA, p < 0.05. 
after stent implantation is performed insmall arteries 
such as the coronary arteries. Previous tudies by us 
häve demonstrated reduction in in vitro platelet 
adhesion to polymer/biopolymer poly-KSPA sur- 
faces containing laminin compared with poly-KSPA 
surfaces alone, 8and similar surfaces can be grafted 
onto stainless steel alloys with the techniques de- 
scribed hefe. Inclusion of attachment proteins with 
limited platelet reactivity in the hydrophilic polymer 
surfaces may also be necessary to improve the poor 
endothelial cell attachment to the hydrophilic sur- 
faces demonstrated in this study. Such poor endo- 
thelial cell attachment could limit steht surface 
endothelialization, which will ultimately determine 
long-term stent patency. Smdies examining in vivo 
hemocompatibillty and healing of polymer surface- 
modified stents are currently underway, and exami- 
nation of polymer/biopolymer surfäces is also 
planned. 
The mechanism by which the hydrophilic poly- 
mer surface modification used in this study reduces 
initial in vivo platelet adhesion to a stainless teel 
surface remains unclear. It has been generally ob- 
served that adherence of fibroblasts and various 
epithelial and inflammatory cells to highly hydro- 
philic surfaces i  very limited. In addition, previous 
studies have shown that in vitro platelet adhesion to 
hydrophilic surfaces is limited ~7 and that albumin, 
which prevents platelet &position, tends to be 
absorbed by hydrophilic surfaces ~8 (similar to the in 
vitro results reported here). In contrast, with a 
baboon arterial venous hunt model, Horbett et a1.19 
found that polar (hydrophilic) surfaces generally 
accumulated more fibrinogen (which promotes plate- 
let adhesion), and Hanson et al.20 demonstrated that 
platelet consumption was directly related to surface 
water content. Determination of platelet consump- 
tion measures loss of platelets from the circulating 
phtelet pool either from platelet attachanent to the 
surface of the material being studied or from platelet 
removal from the circulation within small throm- 
boemboli formed by transient platelet surface attach- 
ment and activation. This study measured only 
platelet accumulation on the material surface, and 
this difference in technique could account in part for 
the contradictory results. In addition, the hydrophilic 
monomers used for surface modification i this study 
were more highly hydrated and had varying surfaces 
charges compared with the poly(2-hydroxyethyl 
methacrylate-ethyl methacrylate) polymers used by 
Horbett et al. 19 and Hanson et al.,20 and these 
differences in surface chemistry likely influenced the 
results of this study as weH. 
Thrombotic events occurring at the materi- 
al/blood interface are complex, dynamic, and un- 
likely to be simply related to a single factor. The 
results of this study support the complexity of 
thrombogenic surface phenomena in that the plate- 
ler accumulation on two polymers with similar 
contact angles (surface hydrophilicity) but different 
surface charges was significantly different. In vivo 
platelet accumulation on the anionic poly-KSPA 
surface was lower than on the neutral poly-NVP 
surface, and previous tudies have shown that pros- 
thetic materials with a negative surface charge (simi- 
lar to arterial intima) have reduced initial in vivo 
surface thrombogenicity. 2~ Long-term patency of 
negatively charged arterial vascular grafts has not 
been found to be significantly improved, however. 22 
Similarly, previous studies 23,24 have demonstrated 
that materials that adsorb fibrinogen are generally 
thrombogenic, whereas those that adsorb albumin 
are "pacified" to platelets, but results of this smdy 
found that poly-NVP modificd stainless teel sur- 
faces, which absorbed less albumin and fibrinogen 
than plain stainless teel surfaces, and poly-KSPA 
surfaces, which absorbed more albumin than plain 
surfaces but equal amounts of fibrinogen, were both 
less platelet-reactive than plain surfaces. Surface 
adsorption of clotting factors, complement, and 
immunoglobulins also plays an important role in 
determining surface hemocompatibility, and the 
composition of the surface protein coating is dy- 
namic, changing over time in part because of initial 
desorption of proteins with low affinity for a surface 
and subsequent replacement of these proteins by 
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thrombus accumulation and stimulate surface en- 
dothelialization.26 
The initial patency of  arteries stented with me- 
tallic endoluminal prostheses appears to depend on 
the potential for stent surface thrombus accumula- 
tion, whereas the long-term patency ofstented vessels 
is highly dependent on prosthesis urface endothe- 
lialization. 14 This finding is especially true when a 
metallic stent is used in small, low-flow arteries. This 
study has shown that surface modification ofstainless 
steel endoluminal stents with hydrophilic polymers is 
feasible and that such surface modifications appear to 
decrease initial platelet accumulation on the stent 
surface. The long-term effect o f  neutral and ionic 
hydrophilic surface modifications on stent surface 
endothelialization, local intimal thickening, or both 
remains to be investigated as does the utility o f  this 
surface hydrograft o locally deliver drugs or other 
bioactive substances that will influence these pro- 
cesses. However,  the results ofthis study suggest that 
hydrophilic surface modification of  stainless steel 
stents is a promising approach to improving the 
hemocompatibi l ity o f  these endoluminal arterial 
devices. 
Fig. 4. Scanning electron micrographs of plain (top), 
poly-KSPA modified (middle), and poly-NVP modified 
(bottom) Palmaz stainless steel stents after 1 hour of blood 
flow exposure in canine arteriovenous shunt. Significant 
platelet accumulation (small arrow) is seen on surface of 
plain stent (top), whereas red blood cells, white blood cells, 
and some fibrin (large arrows) but few platelets are seen on 
surface of modified stents (middle and bottom). 
adsorption of  different proteins with higher affinity 
(the Vroman effect). 2• In addition, white blood 
cells, which attach to even the most nonthrombo-  
genic surfaces, also release factors that modify local 
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D ISCUSSION 
Dr. M. Kathleen Reilly (Spokane, Wash.). Dr. Saft, 
Dr. Clagett, members, and guests. Dr. Seeger and his 
coworkers are to be congratulated for their persistent and 
dogged devotion to investigating ways to make percuta- 
neous transluminal ngioplasty and steht placement a more 
consistently successful procedure in small-diameter vessels. 
Currently PTLA seems to be foUowing the frustrating and 
well-recognized pattern seen with the development of 
small-diameter prosthetic grafts. At instimtions I am newly 
affiliated with most patients following PTCA with stent 
placement are on such alarming combinauons of heparin, 
Coumadin, dextran, aspirin, and dipyridamole that rela- 
tively minor trauma may be life- or limb-threatening. 
In this study the authors have coated both stainless steel 
slabs and Palmaz stents with either neutral or anionic 
hydrophilic polymers. They have shown in vitro platelet 
adherence to be reduced between 60% and 80% for neutral 
or anionic polymers and about 70% platelet adherence 
decrease in vivo. This appears to be independent of passive 
protein absorption where albumin adherence was de- 
creased about 30% to neutral polymers but increased 20% 
to anionic polymers. When they looked at in vivo platelet 
adherence to stents, significant reductions were seen over 
control. However, the reductions were not as much as 
might be hoped for based on the studies with slabs, and this 
leads to my first series of questions. 
You present only the results of the in vivo studies with 
coated stents. What happened to the in vitro platelet 
adherence to stents? Was it more effectively d¢creased, less 
effectively decreased, or the same as in vivo? You ex- 
plained the greater platelet adherence to stents by im- 
plicating the rougher sufface seen in scanning EM. Do 
you therefore have a less uniform polymer coating on 
stents? Could it not also be merely a function of the 
surface area available to interact with platelets? Are the 
surface areas of the slabs and the stents the same? When 
you harvested your coated slabs or stents, were you able 
to repeat the x-ray photoelectron spectrometry? How 
stable is your polymer coating after being subjected to 
1 hour ofhigh-flow perfusion in an AV fistula? What were 
the flow characteristics of your fistulas? Were they main- 
tained relatively constant? Significant alterations in flow 
rates have been shown to affect white cell, platelet, and 
red cell adherence and thrombus thickness. 
I found your studies of endothelial ceU adhesion most 
interesting. As you note in your discussion, long-term 
patency of stented vessels is highly dependent on prosthesis 
surface endothelialization. It is well known that endothe- 
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lium will aggressively cover fibrin-coated metal surfaces but 
does not grow on polymeric surfaces. Might you be 
sacrificing long-term patency for a short-term decrease in 
thrombogenicity? 
Finally, you speak volumes when you stare that 
"thrombogenic events occurring at the material blood 
interface are complex, dynamic and unlikely to be simply 
related to a single factor." It is, however, only by dissecting 
out and examining each single factor that we might some 
day come to a more profound understanding of the whole 
system. I applaud your efforts and appreciate your provid- 
ing me with a copy of your manuscript in advance. I also 
would like to thank the society for the opportunity to 
discuss this important and interesting paper. 
Dr. James M. Seeger. Thank you, Dr. Reilly, for your 
insightfnl questions. I will try to answer them in order. 
We did not smdy cellular adhesion to stents in vitro. 
The reason for that was very straightforward in that we had 
a fairly difficult ime getting asufficient number ofstents to 
do out studies. Therefore I cannot answer some of the 
questions you asked about in vitro interaction between 
stents and platelets, and how surface roughness affects this. 
However, there is some basic work by Baier in the early 
196Os that does show a direct relationship between surface 
roughness and platelet adhesion. Regardless, I do not think 
that increasing surface area is the reason that platelet 
adhesion increases, as all of the labeled platelet accumula- 
tion data were indexed to surface area. 
Did we do XPS studies after the stent had been in place 
to determine stability of the polymer? No, we have not 
done that. The XPS smdies are somewhat difficult to 
interpret once the surface has a protein layer on it, but we 
do have some flow studies in an in vitro model to suggest 
the polymer is stable on the surface. In addition, the 
modification process we are using produces a covalent 
bonding of the polymer to the surface. 
Flow characteristics of the shunt were controlled 
carefully, and the average flow rate was approximately 300 
cc/min. The animals, as is noted in the manuscript, 
underwent heparinization to maintain patency of the shunt, 
and ACT levels were carefully controlled. 
I think the question of endothelial cell growth is a very 
very important one. The problem, as you well know, is that 
endothelial cells and platelets rend to adhere to the same 
surfaces, so how do you produce a surface that is 
nonthrombogenic and that has improved endothelial cell 
growth? It has been our approach to begin by attempting 
to produce anonadhesive surfäce to all cells, and then once 
we have that surface add back those things that may 
specifically improve endothelial cell adhesion. We have 
some work on prosthetic graft surfaces that has shown that 
addition oflaminin to the surface graft increases endothelial 
cell adhesion and at the same time further decreases platelet 
adhesion. There are obviously other attachment proteins 
and growth factors that can be added to the surfaces, 
possibly using bioerodable attachments that may addition- 
ally affect surface ndothelialization. This is going to be the 
tough problem without any question. 
Dr. Lazar Greenfield (Ann Arbor, Mich.). I applaud 
your efforts, because certainty we will see more and more 
metal within the vascular system. What we learned on the 
venous ide in the fabrication of stainless steel Wire filters is 
that there are many ways to finish stainless steel in terms of 
how it is polished, how it is finished, and by passivation. I 
am also curious about whether you have comparability of
treatment of your control piece of stainless teel versus the 
stents that were actually used. In other words, were you 
really comparing the same quality of surface on both of 
those models? I am also very interested inwhat you project 
to be the durability of the coating. There are many ways in 
which coatings can be applied including the possibility of 
adding heparin, and I wonder if you have considered that 
particular addition. 
Dr. Seeger. First, the stainless teel stents and the 
stainless teel-modified stents were initially cleaned and 
prepared in the same manner as the plain stents are, so as 
rar as we know the surfaces are fairly equivalent before 
surface modification. 
How stable this surface is over time remains to be 
&termine& However, the hydrograft surface we applied to 
the stents is actually now in clinical trials in the form of 
surface-modified intraocular lenses. In part, we started 
looking at this surface modification technique because 
previous work with modified intraocular lenses in vivo and 
now in humans had shown the surface to persist for long 
periods at least in the eye. We do not have any long-term 
studies in the bloodstream. 
Can you add heparin to the surface? You can add 
heparin to a surface, as you know, in many manners. 
Heparin can be incorporated irectly into our surface 
hydrograft, but so rar we have not seen much heparin effect 
when this has been done. What we are currently looking at 
is a bioerodable system in which you bulk load the 
hydrograft with proteins and then chemically attach various 
active substances such as heparin to those proteins. The 
attached substances will then be released over various 
lengths of time depending on how the attachment is done. 
Dr. G. Patrick Clagett (Dallas, Texas). You looked at 
platelets, but that is only one part of the story. Have you 
iooked at other indexes of  blood biomaterial interaction 
such as thrombin generation, complement generation, and 
white cell acnvation? 
Dr. Seeger. We have not as of yet, but those are very 
important questions. The other related question that no 
one has brought up is that of  platelet adhesion versus 
platelet consumption after blood exposure to a sufface. We 
looked at platelet adhesion and not at platelet consumption, 
which could be induced by transient platelet interaction 
with the surface-forming microemboli. We are currently 
looking at that at this point in time. 
